Blood-brain barrier dysfunction in ischemic stroke: Targeting tight junctions and transporters for vascular protection

Wazir Abdullahi, Dinesh Tripathi, Patrick T Ronaldson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The blood-brain barrier (BBB) is a physical and biochemical barrier that precisely controls cerebral homeostasis. It also plays a central role in the regulation of blood-to-brain flux of endogenous and exogenous xenobiotics and associated metabolites. This is accomplished by molecular characteristics of brain microvessel endothelial cells such as tight junction protein complexes and functional expression of influx and efflux transporters. One of the pathophysiological features of ischemic stroke is disruption of the BBB, which significantly contributes to development of brain injury and subsequent neurological impairment. Biochemical characteristics of BBB damage include decreased expression and altered organization of tight junction constituent proteins as well as modulation of functional expression of endogenous BBB transporters. Therefore, there is a critical need for development of novel therapeutic strategies that can protect against BBB dysfunction (i.e., vascular protection) in the setting of ischemic stroke. Such strategies include targeting tight junctions to ensure that they maintain their correct structure or targeting transporters to control flux of physiological substrates for protection of endothelial homeostasis. In this review, we will describe the pathophysiological mechanisms in cerebral microvascular endothelial cells that lead to BBB dysfunction following onset of stroke. Additionally, we will utilize this state-of-the-art knowledge to provide insights on novel pharmacological strategies that can be developed to confer BBB protection in the setting of ischemic stroke.

Original languageEnglish (US)
Pages (from-to)C343-C356
JournalAmerican Journal of Physiology - Cell Physiology
Volume315
Issue number3
DOIs
StatePublished - Sep 6 2018

Fingerprint

Tight Junctions
Blood-Brain Barrier
Blood Vessels
Stroke
Tight Junction Proteins
Homeostasis
Endothelial Cells
Architectural Accessibility
Brain
Xenobiotics
Microvessels
Brain Injuries
Pharmacology

Keywords

  • Blood-brain barrier
  • Endothelial cell
  • Oxidative stress
  • Tight junctions
  • Transporters

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Cite this

Blood-brain barrier dysfunction in ischemic stroke : Targeting tight junctions and transporters for vascular protection. / Abdullahi, Wazir; Tripathi, Dinesh; Ronaldson, Patrick T.

In: American Journal of Physiology - Cell Physiology, Vol. 315, No. 3, 06.09.2018, p. C343-C356.

Research output: Contribution to journalArticle

@article{0fdd630375b64f809e277ddfd74629d2,
title = "Blood-brain barrier dysfunction in ischemic stroke: Targeting tight junctions and transporters for vascular protection",
abstract = "The blood-brain barrier (BBB) is a physical and biochemical barrier that precisely controls cerebral homeostasis. It also plays a central role in the regulation of blood-to-brain flux of endogenous and exogenous xenobiotics and associated metabolites. This is accomplished by molecular characteristics of brain microvessel endothelial cells such as tight junction protein complexes and functional expression of influx and efflux transporters. One of the pathophysiological features of ischemic stroke is disruption of the BBB, which significantly contributes to development of brain injury and subsequent neurological impairment. Biochemical characteristics of BBB damage include decreased expression and altered organization of tight junction constituent proteins as well as modulation of functional expression of endogenous BBB transporters. Therefore, there is a critical need for development of novel therapeutic strategies that can protect against BBB dysfunction (i.e., vascular protection) in the setting of ischemic stroke. Such strategies include targeting tight junctions to ensure that they maintain their correct structure or targeting transporters to control flux of physiological substrates for protection of endothelial homeostasis. In this review, we will describe the pathophysiological mechanisms in cerebral microvascular endothelial cells that lead to BBB dysfunction following onset of stroke. Additionally, we will utilize this state-of-the-art knowledge to provide insights on novel pharmacological strategies that can be developed to confer BBB protection in the setting of ischemic stroke.",
keywords = "Blood-brain barrier, Endothelial cell, Oxidative stress, Tight junctions, Transporters",
author = "Wazir Abdullahi and Dinesh Tripathi and Ronaldson, {Patrick T}",
year = "2018",
month = "9",
day = "6",
doi = "10.1152/ajpcell.00095.2018",
language = "English (US)",
volume = "315",
pages = "C343--C356",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Blood-brain barrier dysfunction in ischemic stroke

T2 - Targeting tight junctions and transporters for vascular protection

AU - Abdullahi, Wazir

AU - Tripathi, Dinesh

AU - Ronaldson, Patrick T

PY - 2018/9/6

Y1 - 2018/9/6

N2 - The blood-brain barrier (BBB) is a physical and biochemical barrier that precisely controls cerebral homeostasis. It also plays a central role in the regulation of blood-to-brain flux of endogenous and exogenous xenobiotics and associated metabolites. This is accomplished by molecular characteristics of brain microvessel endothelial cells such as tight junction protein complexes and functional expression of influx and efflux transporters. One of the pathophysiological features of ischemic stroke is disruption of the BBB, which significantly contributes to development of brain injury and subsequent neurological impairment. Biochemical characteristics of BBB damage include decreased expression and altered organization of tight junction constituent proteins as well as modulation of functional expression of endogenous BBB transporters. Therefore, there is a critical need for development of novel therapeutic strategies that can protect against BBB dysfunction (i.e., vascular protection) in the setting of ischemic stroke. Such strategies include targeting tight junctions to ensure that they maintain their correct structure or targeting transporters to control flux of physiological substrates for protection of endothelial homeostasis. In this review, we will describe the pathophysiological mechanisms in cerebral microvascular endothelial cells that lead to BBB dysfunction following onset of stroke. Additionally, we will utilize this state-of-the-art knowledge to provide insights on novel pharmacological strategies that can be developed to confer BBB protection in the setting of ischemic stroke.

AB - The blood-brain barrier (BBB) is a physical and biochemical barrier that precisely controls cerebral homeostasis. It also plays a central role in the regulation of blood-to-brain flux of endogenous and exogenous xenobiotics and associated metabolites. This is accomplished by molecular characteristics of brain microvessel endothelial cells such as tight junction protein complexes and functional expression of influx and efflux transporters. One of the pathophysiological features of ischemic stroke is disruption of the BBB, which significantly contributes to development of brain injury and subsequent neurological impairment. Biochemical characteristics of BBB damage include decreased expression and altered organization of tight junction constituent proteins as well as modulation of functional expression of endogenous BBB transporters. Therefore, there is a critical need for development of novel therapeutic strategies that can protect against BBB dysfunction (i.e., vascular protection) in the setting of ischemic stroke. Such strategies include targeting tight junctions to ensure that they maintain their correct structure or targeting transporters to control flux of physiological substrates for protection of endothelial homeostasis. In this review, we will describe the pathophysiological mechanisms in cerebral microvascular endothelial cells that lead to BBB dysfunction following onset of stroke. Additionally, we will utilize this state-of-the-art knowledge to provide insights on novel pharmacological strategies that can be developed to confer BBB protection in the setting of ischemic stroke.

KW - Blood-brain barrier

KW - Endothelial cell

KW - Oxidative stress

KW - Tight junctions

KW - Transporters

UR - http://www.scopus.com/inward/record.url?scp=85053619240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053619240&partnerID=8YFLogxK

U2 - 10.1152/ajpcell.00095.2018

DO - 10.1152/ajpcell.00095.2018

M3 - Article

C2 - 29949404

AN - SCOPUS:85053619240

VL - 315

SP - C343-C356

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 3

ER -